BusinessActinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 ConferenceBy Nasdaq OMXJan 4, 2017, 12:00 PM UTC
BusinessActinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of Analytical Development to Support BLA and IND Enabling Analytical Studies for Current and Future Clinical ProgramsBy Nasdaq OMXDec 19, 2016, 12:00 PM UTC
BusinessActinium Pharmaceuticals Announces Submission of EU Orphan Designation Application for Actimab-ABy Nasdaq OMXDec 13, 2016, 12:00 PM UTC
BusinessActinium to Sponsor Upcoming Blood & Marrow Transplant Information Network Webinar Focused on Stem Cell Transplants for Patients with AMLBy Nasdaq OMXDec 12, 2016, 12:00 PM UTC
BusinessActinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual MeetingBy Nasdaq OMXDec 6, 2016, 2:00 AM UTC
BusinessActinium Further Strengthens Clinical Development Team with Senior Hire to Support Later-Stage Clinical TrialsBy Nasdaq OMXNov 29, 2016, 12:00 PM UTC
BusinessActinium Issues Letter to Shareholders Highlighting 2016 Accomplishments and Anticipated Milestones for 2017By Nasdaq OMXNov 22, 2016, 12:00 PM UTC
BusinessActinium Pharmaceuticals to Present at LD Micro Main Event Investor ConferenceBy Nasdaq OMXNov 21, 2016, 12:00 PM UTC
